focusIR Fireside Chats podcast - FTSE 250 Fund Manager Reveals Hidden Emerging Market Gems | Infrastructure. Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share Price (IMM)

Share Price Information for Immupharma (IMM)

Share Price is delayed by 15 minutes
Get Live Data
4.30    -0.395 (-8.41%)
Bid:
4.305
Ask:
4.56
Spread: 0.255 (5.923%)
Market Cap: £26.83m
IMM Live PriceLast checked at - London Stock Exchange

Intraday Immupharma Share Chart

Immupharma Share Price
Price 4.30 Open 4.305
Bid 4.305 High 4.48
Ask 4.56 Low 4.30
Change -0.395 (-8.41%) Close 4.695
Volume 1,078,520
Currency GBX
Issue Country GB
Shares in Issue 623.91m
Market Cap £26.83m
PE Ratio -7.166667
EPS -0.60
Year High 19.00
Year High Date 15-Sep-2025
Year Low 1.40
Year Low Date 13-Aug-2025
Dividend 0.00
Yield 0.00%
# Trades 43
Vol. Sold 444,224
Sold Value £19.51k
Vol. Bought 623,372
Bought Value £28.13k
Market Size 75,000
What if I invested £1,000 in Immupharma?
£ 955.56 (-4.44%)
1 month ago
£ 518.70 (-48.13%)
3 months ago
£ 641.79 (-35.82%)
6 months ago
£ 1,619.59 (+61.96%)
1 year ago
Add IMM to WatchlistAdd IMM to Watchlist

Compare Broker Offers

Selected partners may offer promotions for new customers. We may earn a referral fee if you open an account

Great for:
Active Traders
View Offer
Capital at risk
Great for:
Copy Trading
View Offer
Other fees apply.
Capital at risk.
Great for:
ISAs & SIPPs
View Offer
Capital at risk
Great for:
Beginner Friendly
View Offer
Capital at risk
Immupharma Plc Ord 1p

Immupharma is listed in the FTSE AIM All-Share index.

Immupharma is listed in the Medicine and Biotech sector.

Immupharma Plc Ord 1p is listed on the London Stock Exchange trading with ticker code IMM.L. It has a market capitalisation of £26.83m, with approximately 623.91m shares in issue. Over the last year, Immupharma share price has been traded in a range of 17.60, hitting a high of 19.00, and a low of 1.40.

ImmuPharma is a British pharmaceutical company headquartered in London, specialising in the development of innovative drugs for unmet medical needs. Founded in 2004, the company focuses on advancing its proprietary pipeline, which includes treatments for autoimmune diseases, inflammation, and cancer. ImmuPharma's lead candidate, Lupuzor™, targets lupus, a chronic autoimmune condition. Committed to scientific excellence and rigorous clinical research, the company aims to bring breakthrough therapies to market, improving patient outcomes and quality of life. With strategic partnerships and a dedicated team, ImmuPharma strives to make significant contributions to global healthcare.

Some Videos You Might Like

Wishbone Gold: Proposed Acq...


 

What's Hot during War


What's Hot end of April


Recent Share Trades for Immupharma (IMM)

Date Time Trade Prc Volume Buy/Sell Bid Ask Value  
22-May-2616:35:254.30394Unknown*4.3054.5616.94O Ordinary
Delayed publication
Was reported as OTC
22-May-2616:35:254.30187Unknown*4.3054.568.04O Ordinary
Delayed publication
Was reported as OTC
22-May-2616:35:254.30337Unknown*4.3054.5614.49O Ordinary
Delayed publication
Was reported as OTC
22-May-2616:35:254.3010,006Unknown*4.3054.56430.26O Ordinary
Delayed publication
Was reported as OTC
22-May-2616:35:254.3010,532Sell*4.3054.56452.88UT Uncrossing Trade
22-May-2616:24:134.508110,949Buy*4.3054.56493.59O Ordinary
22-May-2616:07:414.4830,000Buy*4.3054.481,344A Automatic Execution
22-May-2616:06:274.372698,000Sell*4.3054.6954,285O Ordinary
22-May-2616:05:484.69539Buy*4.3054.6951.83O Ordinary
Trade was executed as an SI
22-May-2615:24:114.62108,138Buy*4.3054.704,996O Ordinary

Directors Deals for Immupharma (IMM)

Announced Traded Action Notifier Price Currency Amount Holding
11-Aug-2210-Aug-22PlacingTim Franklin held the position of Chief Operating Officer at the time of this trade.Tim Franklin5.00GBX400,000525,000
11-Aug-2210-Aug-22PlacingLisa Baderoon held the position of Non-Executive Director at the time of this trade.Lisa Baderoon5.00GBX400,000583,963
11-Aug-2210-Aug-22PlacingTimothy Paul McCarthy held the position of Non-Executive Chairman at the time of this trade.Timothy Paul McCarthy5.00GBX1,200,0001,488,462
24-Aug-2124-Aug-21BuyTim Franklin held the position of Chief Operating Officer at the time of this trade.Tim Franklin8.26GBX125,000125,000
24-Aug-2123-Aug-21BuyTimothy Paul McCarthy held the position of CEO at the time of this trade.Timothy Paul McCarthy8.26GBX250,000288,462